| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.52B | — | +8.1% |
| Cost of Revenue | $2.36B | — | +12.7% |
| Gross Profit | $1.16B | — | -0.3% |
| R&D Expense | $248.6M | — | +12.0% |
| SG&A Expense | $928.8M | — | -2.0% |
| Operating Income | -$79.7M | — | +97.2% |
| Interest Expense | $120.1M | — | +4.0% |
| Pre-tax Income | -$247.3M | — | +92.0% |
| Income Tax | -$423.7M | — | -670.4% |
| Net Income | $176.4M | — | +105.8% |
| EPS (Basic) | $0.15 | — | +105.9% |
| EPS (Diluted) | $0.15 | — | +105.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.80B | +36.4% | +139.0% |
| Accounts Receivable | $3.08B | +1.5% | -1.6% |
| Inventory | $3.93B | -1.8% | -4.1% |
| Current Assets | $10.92B | +11.5% | +13.5% |
| Total Assets | $36.83B | -1.0% | -4.3% |
| Current Liabilities | $6.81B | -4.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $388.3M | — | -27.5% |
| Capital Expenditures | $39.9M | — | -6.3% |
| Investing Cash Flow | $277.4M | — | +526.1% |
| Financing Cash Flow | -$203.8M | — | +56.4% |
| Free Cash Flow | $348.4M | — | -29.3% |
| +19.1% |
| Long-term Debt | $12.41B | -0.5% | -12.4% |
| Total Liabilities | $22.18B | -1.4% | -2.8% |
| Stockholders' Equity | $14.66B | -0.4% | -6.3% |